RA

Reinhard Ambros

Europe, Basel-Stadt, Switzerland, Basel

Description

Reinhard Ambros

Investor Profile

Reinhard Ambros has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series A (100%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Reinhard Ambros frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
BB
Europe, Zug, Switzerland, Zug
Co-Investments: 1
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Wille Finance
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Schroder Adveq
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1

Which angels does Reinhard Ambros often collaborate with?

DV
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by Reinhard Ambros?

ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series ADec 10, 2019
Amount Raised: $15,235,015